Drug Shortage Report for MYLAN-VARDENAFIL
Report ID | 186414 |
Drug Identification Number | 02464225 |
Brand name | MYLAN-VARDENAFIL |
Common or Proper name | VARDENAFIL |
Company Name | MYLAN PHARMACEUTICALS ULC |
Market Status | MARKETED |
Active Ingredient(s) | VARDENAFIL |
Strength(s) | 10MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 4BL |
ATC code | G04BE |
ATC description | OTHER UROLOGICALS, INCL ANTISPASMODICS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2023-03-15 |
Actual start date | |
Estimated end date | 2023-03-21 |
Actual end date | 2023-03-14 |
Shortage status | Avoided shortage |
Updated date | 2023-03-20 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
Company contact information | Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2023-03-07 | English | Compare |
v2 | 2023-03-07 | French | Compare |
v3 | 2023-03-16 | English | Compare |
v4 | 2023-03-20 | English | Compare |
v5 | 2023-03-20 | French | Compare |
Showing 1 to 5 of 5